ストックスクリーナーアプリを入手
1.13
5.04%
-0.06
アフターアワーズ：
1.14
0.01
+0.88%
前日終値:
$1.19
開ける：
$1.19
24時間の取引高:
684.98K
Relative Volume:
0.66
時価総額：
$135.09M
収益：
$4.35M
当期純損益:
$-45.53M
株価収益率:
-1.0463
EPS:
-1.08
ネットキャッシュフロー:
$-44.79M
1週間 パフォーマンス:
-12.06%
1か月 パフォーマンス:
-31.52%
6か月 パフォーマンス:
+8.65%
1年 パフォーマンス:
+21.54%
1日の値動き範囲:
$1.12
$1.2076
1週間の範囲:
$1.12
$1.30
52週間の値動き範囲:
$0.681
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
LUCD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.13 | 135.09M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-27 | 開始されました | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 開始されました | BTIG Research | Buy |
| 2021-11-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 開始されました | Needham | Buy |
Lucid Diagnostics Inc (LUCD) 最新ニュース
Financial Analysis: Lucid Diagnostics Inc (LUCD)’s Ratios Unveil Key Insights - DWinneX
Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Lucid Diagnostics Inc. (NASDAQ:LUCD) Shares Bought by Geode Capital Management LLC - Defense World
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Kilgore News Herald
LPL Financial LLC Raises Stock Holdings in Lucid Diagnostics Inc. (NASDAQ:LUCD) - Defense World
PAVmed Sets Key Q1 2025 Earnings Call: MedTech Growth Strategy and Financial Results Coming May 15 - Stock Titan
Lucid reports encouraging results from EsoGuard study - MSN
Lucid Diagnostics (LUCD) Showcases Promising Data for EsoGuard T - GuruFocus
A look into Lucid Diagnostics Inc (LUCD)’s deeper side - Sete News
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - BioSpace
PAVmed, Lucid post encouraging results from EsoGuard study (LUCD:NASDAQ) - Seeking Alpha
Lucid Reports Positive Data For EsoGuard Esophageal DNA Test In Patients Without Symptomatic GERD - Nasdaq
Lucid DiagnosticsNarrowing Losses, Expanding Opportunities In Esophageal Cancer Care - RTTNews
Did Lucid Diagnostics Inc (LUCD) perform well in the last session? - uspostnews.com
Ascendiant Capital Markets Forecasts Strong Price Appreciation for Lucid Diagnostics (NASDAQ:LUCD) Stock - The AM Reporter
Lucid Diagnostics (NASDAQ:LUCD) Price Target Raised to $7.50 at Ascendiant Capital Markets - Defense World
Stock Performance Spotlight: Lucid Diagnostics Inc (LUCD) Ends the Day at 1.21, Up by 11.01 - DWinneX
Lucid Diagnostics (LUCD) Sees Price Target Increase Amid Growth Potential | LUCD Stock News - GuruFocus
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - ADVFN
PAVmed Provides Business Update and Second Quarter 2024 Financial Results - ADVFN
Lucid Diagnostics finalizes public offering of common stock - Medical Buyer
Lucid Diagnostics’ (LUCD) Buy Rating Reiterated at Needham & Company LLC - Defense World
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - The Bradford Era
Lucid Diagnostics Closes $16.1 Million Public Offering - MSN
Lucid Diagnostics completes $16.1 million stock offering By Investing.com - Investing.com South Africa
Lucid Diagnostics Raises $16.1 Mln Through Public Offering To Support Corporate Growth - Nasdaq
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN
Lucid Diagnostics Inc (LUCD) With A Potential Upside Of More Than -100.0% - stocksregister.com
Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Benzinga
Lucid Diagnostics Announces Closing of Public Offering of Common Stock - GuruFocus
Lucid Diagnostics completes $16.1 million stock offering - Investing.com Australia
Lucid Diagnostics Announces Closing Of Public Offering Of Common Stock - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Lucid Diagnostics Shares Fall After Pricing Stock Offering - marketscreener.com
Lucid Diagnostics Announces Public Stock Offering - TipRanks
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway - MSN
Lucid Diagnostics Announces Proposed Public Offering of Common Stock - The Malaysian Reserve
Lucid Diagnostics announces proposed public offering of common stock - MSN
Lucid Diagnostics Announces Pricing Of Public Offering Of Common Stock - MarketScreener
Lucid Diagnostics plans stock offering to boost capital By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces Proposed Public Offering of Common S - GuruFocus
SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow
Lucid Diagnostics plans stock offering to boost capital - Investing.com Australia
Lucid Diagnostics Announces Proposed Public Offering Of Common Stock - MarketScreener
Lucid Diagnostics Inc (LUCD) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
0.79%
大文字化:
|
ボリューム (24 時間):